Best TWAS P=1.835398e-08 · Best GWAS P=2.638565e-08 conditioned to 1
# | Tissue | Gene | Modality | RNA phenotype | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Adipose | Dhps | gene expression | ENSRNOG00000004219 | 0.08 | 0.07 | top1 | 1 | 0.07 | 1.7e-08 | -5.3 | 5.3 | 1.1e-07 | -0.96 | 0.14 | 0.86 | FALSE |
2 | Adipose | Cacna1a | gene expression | ENSRNOG00000052707 | 0.07 | 0.05 | lasso | 14 | 0.05 | 1.6e-06 | -5.0 | -5.2 | 1.8e-07 | 0.87 | 0.24 | 0.75 | FALSE |
3 | Adipose | Cesl1 | intron excision ratio | chr19:22684897:22686745 | 0.03 | 0.02 | enet | 8 | 0.03 | 3.0e-04 | -5.0 | -5.2 | 1.7e-07 | 0.91 | 0.03 | 0.85 | FALSE |
4 | BLA | Gcdh | gene expression | ENSRNOG00000003307 | 0.45 | 0.36 | top1 | 1 | 0.36 | 2.7e-20 | -5.2 | -5.2 | 2.6e-07 | 0.92 | 0.39 | 0.61 | FALSE |
5 | BLA | Mri1 | gene expression | ENSRNOG00000026211 | 0.31 | 0.21 | top1 | 1 | 0.21 | 1.8e-11 | -5.4 | 5.4 | 6.2e-08 | -0.99 | 0.17 | 0.83 | FALSE |
6 | BLA | Brme1 | mRNA stability | ENSRNOG00000025796 | 0.09 | 0.06 | lasso | 14 | 0.06 | 4.3e-04 | -5.5 | -5.5 | 3.9e-08 | 1.00 | 0.16 | 0.80 | FALSE |
7 | Brain | Gcdh | gene expression | ENSRNOG00000003307 | 0.59 | 0.53 | lasso | 14 | 0.57 | 5.0e-64 | -5.1 | -5.3 | 1.4e-07 | 0.96 | 0.13 | 0.87 | FALSE |
8 | Brain | Nfix | mRNA stability | ENSRNOG00000002983 | 0.07 | 0.03 | top1 | 1 | 0.03 | 1.4e-03 | -5.1 | 5.1 | 2.7e-07 | -0.86 | 0.07 | 0.08 | FALSE |
9 | Brain | Gcdh | mRNA stability | ENSRNOG00000003307 | 0.13 | 0.09 | enet | 56 | 0.10 | 4.2e-09 | -5.1 | 5.2 | 2.4e-07 | -0.88 | 0.37 | 0.63 | FALSE |
10 | Brain | Brme1 | mRNA stability | ENSRNOG00000025796 | 0.06 | 0.05 | top1 | 1 | 0.05 | 2.1e-05 | -5.5 | -5.5 | 4.6e-08 | 0.97 | 0.11 | 0.80 | FALSE |
11 | IL | Gcdh | gene expression | ENSRNOG00000003307 | 0.58 | 0.35 | lasso | 5 | 0.36 | 1.3e-09 | -5.0 | -5.2 | 2.3e-07 | 0.81 | 0.20 | 0.80 | FALSE |
12 | LHb | Gcdh | mRNA stability | ENSRNOG00000003307 | 0.24 | 0.12 | top1 | 1 | 0.12 | 1.1e-03 | -5.1 | 5.1 | 2.7e-07 | -0.88 | 0.04 | 0.06 | FALSE |
13 | Liver | Gcdh | gene expression | ENSRNOG00000003307 | 0.33 | 0.29 | enet | 174 | 0.30 | 4.2e-34 | -5.5 | -5.5 | 4.1e-08 | 0.96 | 0.11 | 0.89 | FALSE |
14 | Liver | Trmt1 | isoform ratio | ENSRNOT00000003941 | 0.05 | 0.04 | top1 | 1 | 0.04 | 5.8e-05 | -5.4 | 5.4 | 7.9e-08 | -0.97 | 0.12 | 0.37 | FALSE |
15 | Liver | Trmt1 | isoform ratio | ENSRNOT00000098952 | 0.03 | 0.02 | top1 | 1 | 0.02 | 1.2e-03 | -5.4 | -5.4 | 7.9e-08 | 1.00 | 0.04 | 0.06 | FALSE |
16 | Liver | Gcdh | isoform ratio | ENSRNOT00000116825 | 0.03 | 0.03 | top1 | 1 | 0.03 | 1.4e-04 | -5.2 | 5.2 | 2.6e-07 | -1.00 | 0.06 | 0.10 | FALSE |
17 | NAcc | Mri1 | gene expression | ENSRNOG00000026211 | 0.20 | 0.07 | top1 | 1 | 0.07 | 9.7e-03 | -5.5 | 5.5 | 4.7e-08 | -0.91 | 0.08 | 0.07 | FALSE |
18 | NAcc | Rnaseh2a | gene expression | ENSRNOG00000068063 | 0.23 | 0.07 | top1 | 1 | 0.07 | 1.2e-02 | -5.4 | 5.4 | 7.9e-08 | -0.84 | 0.04 | 0.08 | FALSE |
19 | NAcc2 | Cacna1a | alternative TSS | ENSRNOT00000083448 | 0.07 | 0.03 | blup | 1513 | 0.03 | 1.1e-02 | -5.5 | 5.6 | 1.8e-08 | -0.95 | 0.18 | 0.67 | TRUE |
20 | NAcc2 | Cacna1a | alternative TSS | ENSRNOT00000102295 | 0.09 | 0.04 | top1 | 1 | 0.04 | 2.5e-03 | -5.5 | -5.5 | 4.2e-08 | 0.99 | 0.07 | 0.13 | FALSE |
21 | NAcc2 | Gcdh | gene expression | ENSRNOG00000003307 | 0.53 | 0.45 | enet | 128 | 0.46 | 3.0e-27 | -5.6 | -5.4 | 7.5e-08 | 0.99 | 0.11 | 0.89 | FALSE |
22 | NAcc2 | Mri1 | gene expression | ENSRNOG00000026211 | 0.24 | 0.10 | enet | 283 | 0.17 | 1.7e-09 | -5.5 | 5.6 | 2.8e-08 | -0.50 | 0.18 | 0.82 | FALSE |
23 | NAcc2 | Rad23a | mRNA stability | ENSRNOG00000003026 | 0.10 | 0.06 | blup | 925 | 0.06 | 3.0e-04 | -5.5 | -5.6 | 1.9e-08 | 0.92 | 0.12 | 0.80 | FALSE |
24 | OFC | Mri1 | gene expression | ENSRNOG00000026211 | 0.31 | 0.15 | top1 | 1 | 0.15 | 2.3e-04 | -5.4 | 5.4 | 5.8e-08 | -0.94 | 0.08 | 0.08 | FALSE |
25 | OFC | Gcdh | intron excision ratio | chr19:23264057:23264177 | 0.23 | 0.03 | blup | 773 | 0.05 | 2.9e-02 | -5.4 | 5.5 | 3.9e-08 | -0.87 | 0.10 | 0.42 | FALSE |
26 | PL2 | Gcdh | gene expression | ENSRNOG00000003307 | 0.54 | 0.39 | lasso | 31 | 0.40 | 5.5e-23 | -5.1 | -5.1 | 3.0e-07 | 0.96 | 0.12 | 0.88 | FALSE |
27 | PL2 | Gcdh | intron excision ratio | chr19:23263340:23263398 | 0.16 | 0.12 | blup | 776 | 0.13 | 1.6e-07 | -5.5 | -5.2 | 2.2e-07 | 0.96 | 0.12 | 0.88 | FALSE |
28 | PL2 | Gcdh | intron excision ratio | chr19:23263527:23263608 | 0.16 | 0.13 | top1 | 1 | 0.13 | 2.0e-07 | -5.5 | 5.5 | 4.7e-08 | -0.95 | 0.11 | 0.88 | FALSE |
29 | PL2 | Gadd45gip1 | mRNA stability | ENSRNOG00000003011 | 0.15 | 0.05 | blup | 955 | 0.10 | 3.6e-06 | 3.4 | -5.1 | 2.8e-07 | 0.75 | 0.64 | 0.34 | FALSE |
h2: Heritability estimate for the given transcriptomic model. PP3: Posterior probability of two distinct causal variants. PP4: Posterior probability of a single shared causal variant. joint: Whether the RNA phenotype is in the joint model.